The Searle Company Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, SEARL's sales rose 12% to Rs 7.4bn, from Rs 6.6bn, and profit after tax was a loss of Rs 1.8bn, against a loss of Rs 1.1bn (compared with Apr–Jun 2025).
Earnings per share were -Rs 3.38, against -Rs 2.00 a year earlier. The company reported a dividend of Rs 1.00 per share for the quarter.
At Rs 75.99, SEARL trades at 24.2 times earnings, with a dividend yield of 1.3%.
- P/E ratio
- 24.2
- Dividend yield
- 1.3%
- Dividend payout
- -30%
- of earnings
- Return on equity
- 2%
- Net margin
- 1.0%
- trailing twelve months
- Debt to equity
- 0.23
SEARL quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 7.4bn | -Rs 1.8bn | -23.9% | -Rs 3.38 | Rs 1.00 |
| Jan–Mar 2026 | Rs 9.7bn | Rs 502.0mn | 5.2% | Rs 0.84 | — |
| Oct–Dec 2025 | Rs 10.0bn | Rs 892.0mn | 9.0% | Rs 1.52 | — |
| Jul–Sep 2025 | Rs 9.7bn | Rs 914.0mn | 9.4% | Rs 1.77 | — |
| Apr–Jun 2025 | Rs 6.6bn | -Rs 1.1bn | -16.5% | -Rs 2.00 | — |
| Jan–Mar 2025 | Rs 7.0bn | -Rs 352.0mn | -5.0% | -Rs 0.70 | — |
| Oct–Dec 2024 | Rs 7.4bn | -Rs 359.0mn | -4.9% | -Rs 0.72 | — |
| Jul–Sep 2024 | Rs 7.6bn | Rs 428.0mn | 5.6% | Rs 0.69 | — |
SEARL annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Jun 2026 | Rs 36.8bn | Rs 535.7mn | Rs 0.75 | Rs 1.00 |
| Year to Jun 2025 | Rs 28.6bn | -Rs 1.4bn | -Rs 2.73 | — |
| Year to Jun 2024 | Rs 29.4bn | -Rs 2.4bn | -Rs 4.96 | — |
| Year to Jun 2023 | Rs 25.8bn | Rs 413.0mn | Rs 0.78 | — |
| Year to Jun 2022 | Rs 29.9bn | Rs 2.4bn | Rs 5.79 | — |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 51.5bn
- Shareholders' equity
- Rs 34.3bn
- Cash & bank
- Rs 2.5bn
- Total debt
- Rs 8.0bn
- Current ratio
- 1.77
- 3-month high
- Rs 99.16
- 3-month low
- Rs 75.99
- 1-month change
- -10.0%
- 3-month change
- -23.4%
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- AGPAGP LtdRs 157.87P/E 12.7
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- LIVENLiven Pharma LimitedRs 31.14
- MACTERMacter International LtdRs 259.64P/E 15.3
SEARL: common questions
What is SEARL's share price?
The Searle Company Ltd (SEARL) last closed at Rs 75.99 on the Pakistan Stock Exchange.
Does SEARL pay a dividend?
Yes. The Searle Company Ltd paid Rs 1.00 per share for the year to Jun 2026, and the stock's dividend yield is 1.3%.
What were SEARL's latest results?
In the Apr–Jun 2026 quarter, SEARL's sales rose 12% to Rs 7.4bn, from Rs 6.6bn, and profit after tax was a loss of Rs 1.8bn, against a loss of Rs 1.1bn (compared with Apr–Jun 2025).
What is SEARL's P/E ratio?
At Rs 75.99, SEARL trades at 24.2 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.